Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Watson Begins Anew As Actavis, Focuses On Organic Growth

This article was originally published in The Pink Sheet Daily

Executive Summary

The traditionally generic-heavy company now has an expanded global presence and a growing branded business to go with its new name.

Advertisement

Related Content

Teva Reorganizes With Emphasis On Strengthening Generics
Teva CEO Suits Up For Acquisitions As A Springboard For Growth
Teva CEO Vigodman Reveals A First Glimpse At His Strategy
Actavis’ Record-Breaking Quarterly Sales Show Success Of Merger Strategy
Actavis’ Big Bet On Diversified Hybrid Model Reflects Industry Trends
Actavis Realigns Business To Increase Efficiency
Three Largest U.S. Generic Firms See Diversification As Best Path Through Reverse Patent Cliff

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS074818

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel